P1.11.05 Efficacy and Multi-Omics Insights of Immune Checkpoint Inhibitors in NSCLC With Leptomeningeal Metastasis
Back to course
Asset Subtitle
Li-Bo Tang
Meta Tag
Speaker Li-Bo Tang
Topic Metastatic Non-small Cell Lung Cancer – Immunotherapy
Powered By